Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. PACS
stocks logo

PACS

-
Add to WatchlistAdvanced Chart
$
0.000
0(0.000%)1D
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
1.10B
+17.85%
0.417
+22.26%
Estimates Revision
The market is revising No Change the revenue expectations for PACS Group, Inc. (PACS) for FY2024, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 40.27%.
Revenue Estimates for FY2024
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2024
Revise Downward
down Image
-4.19%
In Past 3 Month
Stock Price
Go Up
up Image
+40.27%
In Past 3 Month
1 Analyst Rating
up Image0
Wall Street analysts forecast PACS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PACS is 32.00 USD with a low forecast of 32.00 USD and a high forecast of 32.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
up Image0
Current: 12.030
sliders
Low
32.00
Averages
32.00
High
32.00
up Image0
Current: 12.030
sliders
Low
32.00
Averages
32.00
High
32.00
Macquarie
Tao Qiu
Buy
Maintains
$42 → $24
2025-01-06
Reason
Macquarie
Tao Qiu
Price Target
$42 → $24
2025-01-06
Maintains
Buy
Reason
Truist Securities
David Macdonald
Strong Buy
Maintains
$46 → $32
2025-01-06
Reason
Truist Securities
David Macdonald
Price Target
$46 → $32
2025-01-06
Maintains
Strong Buy
Reason
JP Morgan
Lisa Gill
Buy
to
Hold
Downgrades
$18
2024-12-17
Reason
JP Morgan
Lisa Gill
Price Target
$18
2024-12-17
Downgrades
Buy
to
Hold
Reason
JPMorgan downgraded Pacs Group to Neutral from Overweight with an $18 price target. The firm moved to the sidelines after the company postponed its Q3 earnings and said it received civil investigative demands from the federal government regarding its reimbursement and referral practices. This has created a prolonged overhang on the stock, the analyst tells investors in a research note.
Stephens & Co.
Scott Fidel
Buy
Maintains
$48 → $31
2024-11-18
Reason
Stephens & Co.
Scott Fidel
Price Target
$48 → $31
2024-11-18
Maintains
Buy
Reason
Stephens lowered the firm's price target on Pacs Group to $31 from $48 and keeps an Overweight rating on the shares after the company provided notification of late filing with the SEC for its most recent 10-Q and amended its existing credit agreement, providing an extension to the covenant pertaining to delivery of unaudited financial statements. The firm maintains its 2024-2026 adjusted EBITDA estimates, but cites reduced visibility due to the internal audit committee investigation currently underway and an ongoing federal inquiry for its lowered target, pending the Q3 10-Q release.
JP Morgan
Lisa Gill
Buy
Initiates
$40
2024-11-06
Reason
JP Morgan
Lisa Gill
Price Target
$40
2024-11-06
Initiates
Buy
Reason
Truist Securities
David Macdonald
Strong Buy
Maintains
$44 → $46
2024-10-14
Reason
Truist Securities
David Macdonald
Price Target
$44 → $46
2024-10-14
Maintains
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Pacs Group Inc (PACS.N) is 7.69, compared to its 5-year average forward P/E of 13.53. For a more detailed relative valuation and DCF analysis to assess Pacs Group Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
13.53
Current PE
7.69
Overvalued PE
20.11
Undervalued PE
6.95

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average EV/EBITDA
15.21
Current EV/EBITDA
10.99
Overvalued EV/EBITDA
19.72
Undervalued EV/EBITDA
10.70

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
0.83
Current PS
0.45
Overvalued PS
1.25
Undervalued PS
0.41

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

PACS News & Events

Events Timeline

(ET)
2025-06-17
12:01:42
Pacs Group rises 18.5%
select
2025-06-17
10:49:07
Pacs Group committee finds no basis to question CEO, CFO integrity, says Truist
select
2025-06-17
10:47:42
Pacs Group up after saying audit committee probe 'substantially complete'
select
Sign Up For More Events
Sign Up For More Events

News

Preview
4.0
07-03Yahoo Finance
Citizens JMP Maintains Market Perform Rating on Omega Healthcare (OHI)

  • Investment Potential: Omega Healthcare Investors, Inc. (NYSE:OHI) is considered undervalued, with analysts noting improving fundamentals and operational performance despite ongoing scrutiny related to its fifth-largest operator, PACS Group, which faces potential billing violations.

  • Strategic Outlook: Analysts suggest that the issues with PACS Group may prompt Omega Healthcare to pursue a strategic acquisition plan aimed at enhancing growth while minimizing risks associated with the troubled operator.

Preview
4.5
06-23Benzinga
US Stock Futures Rise As Markets Shrug Off Iran Strike Fallout: 'Worst Is Now In The Rear-View Mirror,' Says Top Analyst

  • Market Overview: U.S. stock futures show slight gains amid rising tensions in the Middle East following American airstrikes on Iranian nuclear facilities, with investors cautious about potential escalation and upcoming economic data releases.

  • Sector Performance: The S&P 500 ended down 0.22% last Friday, with mixed sector performances; energy stocks rose while tech and healthcare sectors declined, as analysts express mixed sentiments about market stability amidst geopolitical concerns.

Preview
9.5
06-19NASDAQ.COM
PACS Group, Inc. (PACS) Opinions on Financial Restatement and Audit Update

  • Financial Restatement Announcement: PACS Group, Inc. has announced a financial restatement for Q1 and Q2 of 2024 due to overstated revenue from Medicare services, leading to a significant stock price increase of over 17% after an audit committee found no issues with leadership integrity.

  • Investor Reactions and Market Implications: The news has sparked mixed reactions among investors on X, with some expressing optimism about the audit findings while others are concerned about the implications of the revenue discrepancies on future investor confidence.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Pacs Group Inc (PACS) stock price today?

The current price of PACS is 12.03 USD — it has decreased -2.27 % in the last trading day.

arrow icon

What is Pacs Group Inc (PACS)'s business?

PACS Group, Inc. is a holding company investing in post-acute healthcare facilities, professionals, and ancillary services. The Company is focused on delivering skilled nursing care through a portfolio of independently operated facilities. It also provides its independently operated facilities with a comprehensive suite of technology, support, and back-office services. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. The Company’s independent subsidiaries operate about 314 post-acute care and senior living facilities across 17 states, serving over 30,000 patients daily.

arrow icon

What is the price predicton of PACS Stock?

Wall Street analysts forecast PACS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PACS is 32.00 USD with a low forecast of 32.00 USD and a high forecast of 32.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Pacs Group Inc (PACS)'s revenue for the last quarter?

Pacs Group Inc revenue for the last quarter amounts to 981.85M USD, increased 29.08 % YoY.

arrow icon

What is Pacs Group Inc (PACS)'s earnings per share (EPS) for the last quarter?

Pacs Group Inc. EPS for the last quarter amounts to -0.07 USD, decreased -143.75 % YoY.

arrow icon

What changes have occurred in the market's expectations for Pacs Group Inc (PACS)'s fundamentals?

The market is revising No Change the revenue expectations for PACS Group, Inc. (PACS) for FY2024, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 40.27%.
arrow icon

How many employees does Pacs Group Inc (PACS). have?

Pacs Group Inc (PACS) has 32433 emplpoyees as of July 19 2025.

arrow icon

What is Pacs Group Inc (PACS) market cap?

Today PACS has the market capitalization of 1.91B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free